DOP001 Effectiveness and safety of vedolizumab in anti-TNF naïve patients with inflammatory bowel disease: a multicentre retrospective European Crohn’s and Colitis Organisation study

Uri Kopylov, Marc Ferrante, Luc Biedermann et al.|Journal of Crohn s and Colitis|2018

Cited by 4